Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients with Metastatic Pancreas Adenocarcinoma Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antineoplastic Agents
  • Pancreatic Neoplasms

abstract

  • Receipt of systemic therapy was associated with longer survival in elderly patients¬†‚Č• 75 years of age with metastatic pancreas adenocarcinoma. Therapeutic clinical trial participation among these patients was low and future development of prognostic models for appropriate patient selection is warranted.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4981476

Digital Object Identifier (DOI)

  • 10.1016/j.clcc.2015.05.005

PubMed ID

  • 26072442

Additional Document Info

start page

  • 269

end page

  • 276.e1

volume

  • 14

number

  • 4